TuesdayNov 08, 2022 1:09 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Inks New 22-Device Contract with Florida College

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has signed an agreement to deploy 22 K1 Blue Light Towers at a Florida college. According to the announcement, many schools are ill-equipped to address campus safety challenges because of staffing shortages and budget constraints. Knightscope’s proprietary tech and devices provide key solutions to their challenges. The new college contract includes the retrofitting of 13 emergency call systems and the replacement of older, hardwired towers at two separate locations. The Florida college will be leveraging Knightscope’s cellular and satellite communications with solar power to offer students, faculty and visitors…

Continue Reading

TuesdayNov 08, 2022 12:55 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences 1st-Ever Study Evaluating DehydraTECH-CBD’s Effect on Diabetes

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced that study program DIAB-A22-1 is expected to begin on schedule today. According to the announcement, this is Lexaria’s first-ever study to investigate whether its patented DehydraTECH-processed cannabidiol (“CBD”) may potentially have therapeutic utility against diabetes. The company has evidenced the safety and efficacy of DehydraTECH-CBD in human hypertension studies. Strong connections exist between heart disease, hypertension and diabetes, with hypertension twice as frequent in diabetics and hypertensive patients at greater risk of developing diabetes. Diabetes, which prevents the body from making enough insulin and results in…

Continue Reading

TuesdayNov 08, 2022 12:10 pm

QualityStocksNewsBreaks – FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Enters Assembly, Validation Stage of Its First Farm-Ready Demonstration System

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, is entering the final phase of assembling and validating its on-farm, containerized, green-ammonia production system. The company has announced that it is installing its first full-scale demonstration system on a crop farm in Manitoba; FuelPositive anticipates running the system as a pilot project on the 11,000-acre farm under all types of operating conditions to verify that it can to produce green ammonia that can be used as fertilizer. The company also plans on eventually using the green ammonia as fuel to…

Continue Reading

TuesdayNov 08, 2022 11:15 am

REZYFi, Inc. Leverages Cannabis Industry Interests to Diversify Banking and Real Estate as DCC Prioritizes Research Project Funding

The California Department of Cannabis Control (“DCC”) has reserved $20 million in funding for research prioritizing cannabis projects, including potency, health impact, medicinal use, legacy cannabis genetics, and industry health The medicinal and recreational cannabis market size in the US is anticipated to reach $33 billion in 2022, with a revenue outlook of $52.6 billion by 2026 REZYFi Inc., through two wholly-owned subsidiaries, is positioned to be the first cannabis mortgage banker in the United States The state of California Department of Cannabis Control has reserved $20 million in funding for research that prioritizes numerous cannabis topics, including potency, health…

Continue Reading

TuesdayNov 08, 2022 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Aiming to Address Unmet Patient Needs of Hypertensive Patients

Lexaria just completed its HYPER-H21-4 human clinical hypertension study, posting a sustained drop in blood pressure in normally active hypertensive patients With the success of this study, the company is working towards an IND application to seek FDA approval for its patented DehydraTECH(TM)-enabled CBD capsule formulation.  47% of adults live with hypertension but only 24% of them have it under control With its DehydraTECH-CBD, Lexaria hopes to not only address the severe unmet patient need associated with hypertension but also tap into a market that is set to be valued at $34 billion by 2030 Lexaria Bioscience (NASDAQ: LEXX), a…

Continue Reading

TuesdayNov 08, 2022 9:45 am

Rising Investment In Clean Energy Drives Optimism for Correlate Infrastructure Partners Inc. (CIPI)

Nearly a decade has passed since the Paris Accords established international cooperation on curbing fossil fuel pollutants believed to be responsible for adversely affecting the earth’s climate, and some agencies worry that not enough is happening to meet the accords’ goals Despite concerns about obstacles to renewable energy adoption, the same agencies note that investment in climate-friendly technologies is rising Correlate Infrastructure Partners is a U.S.-based company works with the commercial real estate industry to drive the transition to climate-friendly energy sources, helping clients analyze their utilities use, identifying ways to improve their ESG outcomes, and presenting funding opportunities to…

Continue Reading

TuesdayNov 08, 2022 9:00 am

Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) Set to Benefit from Increased Government Focus on Online Privacy

The U.S. Federal Trade Commission is increasingly seeking to protect the online privacy rights of consumers The FTC recently sued data broker Kochava for brokering the geolocation details of millions of consumers Texas Attorney General Ken Paxton has filed suit against Google for allegedly collecting customer information without consent Reklaim enables users to reclaim their data – providing the option to delete it or monetize it A poll conducted during the summer of 2021 showed that 13 percent of UK teens and 6 percent of American teens linked Instagram usage to suicidal thoughts. Even more surprising is the fact that…

Continue Reading

MondayNov 07, 2022 1:49 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Targeted ‘Finish Line Is Within Sight’ as It Pursues Potential GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP) has been developing drug candidates for treating primary and metastatic brain and central nervous system cancer. “Berubicin, the company’s lead drug candidate, is a novel anthracycline in an ongoing international trail in glioblastoma (“GBM”) treatment. The interim analysis data from this potentially pivotal trial is expected in mid-2023… Berubicin was the first [anthracycline] to provide scientific data which appears to demonstrate its ability to cross the blood-brain barrier and was designed with a molecular target of topoisomerase II enzymes responsible for cleaving and recombing double-stranded DNA during cellular replication,” a recent article explains. “Since the beginning…

Continue Reading

MondayNov 07, 2022 1:30 pm

QualityStocksNewsBreaks – Hillcrest Energy Technologies Ltd.’s (CSE: HEAT) (OTCQB: HLRTF) Enhanced Solution Holds Potential to Simplify, Redefine EV Charging

Hillcrest (CSE: HEAT) (OTCQB: HLRTF), a company developing transformative power conversion technologies, has sought to introduce its proprietary solution into the global vehicle-to-grid technology space. “Hillcrest Energy Technologies has filed a patent for an enhanced powertrain solution, which offers the potential to simplify EV charging and redefine how the industry envisions charging infrastructure. The company believes the most exciting benefits of the enhanced powertrain solution are the ability to eliminate the onboard charger and booster from an EV, as well as faster, anywhere charging including direct DC, wireless and bidirectional charging across current and future power levels,” a recent article…

Continue Reading

MondayNov 07, 2022 12:08 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces Q3-2022 Results, Continued Strengthening of Leading Position in Uranium, Rare Earth Elements

Energy Fuels (NYSE American: UUUU) (TSX: EFR) announced its financial results for the quarter ended Sept. 30, 2022. Among the highlights, the company reported a robust balance sheet with $122.3 million of working capital as of Sept. 30, 2022, including $77.1 million of cash and cash equivalents, $11.6 million of marketable securities, $27.3 million of inventory, and no short-term (or long-term) debt. The company’s product inventory has a value of $44.1 million at current commodity prices. “Energy Fuels continues to strengthen our U.S. market leading position in uranium and rare earth elements, which are both critical to the clean energy…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered